> Chutes & Ladders: NitroMed CEO Michael Loberg and CFO Lawrence Block resigned today. No reason for their sudden departure was given. The company's stock has slid 44 percent this year. Report
> Novavax, which is developing avian and seasonal flu vaccines, is selling $38 million in stock. Report
> Anaclim, an Indianapolis-based clinical trial firm launched by two Lilly veterans, intends to do a better job recruiting minorities for drug studies. Article
> Codexis has signed a research collaboration pact with Schering-Plough. Release
And Finally… A debate has developed over the aggressive use of drugs to deal early on with schizophrenia. Article